Raghdaa H. Al Zarzour
George Town, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic-Oleic Acid-Induced Steatosis in HepG2 Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 27, 2022
Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: May 17, 2022
The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions.
Journal: Life sciences
Published: April 10, 2022
A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Journal: Molecules (Basel, Switzerland)
Published: December 31, 2021
Medicinal plants' proposed nanocomposites for the management of endocrine disorders.
Journal: Heliyon
Published: December 30, 2021
Correction to: COVID‑19 and therapy with essential oils having antiviral, anti‑inflammatory, and immunomodulatory properties.
Journal: Inflammopharmacology
Published: February 20, 2021
Anticlastogenic, antimutagenic, and cytoprotective properties of Orthosiphon stamineus ethanolic leaves extract.
Journal: Drug and chemical toxicology
Published: April 24, 2020
50% Ethanol extract of Orthosiphon stamineus modulates genotoxicity and clastogenicity induced by mitomycin C.
Journal: Drug and chemical toxicology
Published: June 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026